- Home
- MDRR vs ICU Comparison
MDRR vs ICU Comparison
Compare MDRR & ICU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MDRR | ICU |
|---|---|---|
| Founded | 2015 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.0M | 15.9M |
| IPO Year | 2018 | N/A |
Fundamental Metrics
Financial Performance| Metric | MDRR | ICU |
|---|---|---|
| Price | $12.13 | $2.55 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 4.0K | ★ 113.4K |
| Earning Date | 11-06-2025 | 11-13-2025 |
| Dividend Yield | ★ 2.16% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $10,098,461.00 | $881,000.00 |
| Revenue This Year | N/A | $691.85 |
| Revenue Next Year | N/A | $64.17 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 1.83 | ★ 1195.59 |
| 52 Week Low | $9.55 | $2.20 |
| 52 Week High | $14.52 | $30.70 |
Technical Indicators
Market Signals| Indicator | MDRR | ICU |
|---|---|---|
| Relative Strength Index (RSI) | 42.33 | 89.62 |
| Support Level | $12.10 | $2.40 |
| Resistance Level | $12.50 | $2.81 |
| Average True Range (ATR) | 0.32 | 0.09 |
| MACD | -0.01 | 0.28 |
| Stochastic Oscillator | 22.84 | 86.88 |
Price Performance
Historical ComparisonAbout MDRR Medalist Diversified REIT Inc.
Medalist Diversified REIT Inc is engaged to acquire, reposition, renovate, lease, and manage income-producing properties with a focus on commercial properties, including flex-industrial and retail properties, multi-family residential properties, and hotel properties. The company operates as a UPREIT and owns properties through its subsidiary, Medalist Diversified Holdings, LP. Its reportable segments were retail center properties, flex center properties, and STNL properties.
About ICU SeaStar Medical Holding Corporation
SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. The Company is comprised of a single reportable segment, which is its Device Segment.